Evaluation of a spot-on imidacloprid-moxidectin formulation (Advocate®) for the treatment of naturally occurring esophageal spirocercosis in dogs: A double-blinded, placebo-controlled study
- Gilad Segev*
- , Alicia Rojas
- , Eran Lavy
- , Marganit Yaffe
- , Itamar Aroch
- , Gad Baneth
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
11
Scopus
citations